NO971350D0 - Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers - Google Patents

Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers

Info

Publication number
NO971350D0
NO971350D0 NO971350A NO971350A NO971350D0 NO 971350 D0 NO971350 D0 NO 971350D0 NO 971350 A NO971350 A NO 971350A NO 971350 A NO971350 A NO 971350A NO 971350 D0 NO971350 D0 NO 971350D0
Authority
NO
Norway
Prior art keywords
furocoumarin
sensitizers
viral
photodynamic inactivation
bacterial blood
Prior art date
Application number
NO971350A
Other languages
Norwegian (no)
Other versions
NO971350L (en
Inventor
Sang Chul Park
Jr Raymond P Goodrich
Nagender Yerram
Samuel O Sowemino-Coker
Matthew S Platz
Brian Aquila
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/311,125 external-priority patent/US5516629A/en
Priority claimed from US08/343,680 external-priority patent/US6251644B1/en
Application filed by Baxter Int filed Critical Baxter Int
Publication of NO971350D0 publication Critical patent/NO971350D0/en
Publication of NO971350L publication Critical patent/NO971350L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO971350A 1994-09-22 1997-03-21 Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers NO971350L (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/311,125 US5516629A (en) 1990-04-16 1994-09-22 Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
US08/343,680 US6251644B1 (en) 1990-04-16 1994-11-22 Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer
US08/427,080 US5789601A (en) 1990-04-16 1995-04-21 Method of inactivation of viral and bacterial blood contaminants
US08/461,626 US5869701A (en) 1990-04-16 1995-06-05 Method of inactivation of viral and bacterial blood contaminants
PCT/US1995/012069 WO1996008965A1 (en) 1994-09-22 1995-09-21 Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers

Publications (2)

Publication Number Publication Date
NO971350D0 true NO971350D0 (en) 1997-03-21
NO971350L NO971350L (en) 1997-05-22

Family

ID=27502002

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971350A NO971350L (en) 1994-09-22 1997-03-21 Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers

Country Status (5)

Country Link
EP (1) EP0782388A4 (en)
AU (1) AU691672B2 (en)
CA (1) CA2199372A1 (en)
NO (1) NO971350L (en)
WO (1) WO1996008965A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
AU703108B2 (en) * 1995-06-07 1999-03-18 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
DE19853425A1 (en) * 1998-11-19 2000-05-25 Martin Roecken Topical composition containing khellin or its derivatives, useful for phototherapy of psoriasis and eczema, has low mitogenic potential
AUPP751298A0 (en) * 1998-12-04 1999-01-07 Csl Limited Inactivation of non-enveloped viruses
DE10031851B4 (en) * 2000-07-04 2005-10-13 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Photodynamic treatment and UV-B irradiation of a platelet suspension
US8580192B2 (en) 2006-10-31 2013-11-12 Ethicon, Inc. Sterilization of polymeric materials
CN107075478B (en) 2014-07-23 2021-11-09 塞鲁斯公司 Method for preparing platelet product
WO2016057965A1 (en) 2014-10-10 2016-04-14 Cerus Corporation Compositions and methods for treating viral hemorrhagic fever
IL256381B1 (en) 2015-06-26 2024-08-01 Cerus Corp Cryoprecipitate compositions and methods of preparation thereof
US10799533B2 (en) 2015-10-23 2020-10-13 Cerus Corporation Plasma compositions and methods of use thereof
IL260393B2 (en) 2016-01-07 2024-06-01 Cerus Corp Systems and methods for preparation of platelets
MX2019010492A (en) 2017-03-03 2019-11-25 Cerus Corp Kits and methods for preparing pathogen-inactivated platelet compositions.
IL273433B1 (en) 2017-09-20 2024-09-01 Cerus Corp Compositions and methods for pathogen inactivation of platelets
KR20200115498A (en) 2017-12-29 2020-10-07 세루스 코포레이션 Systems and methods for treating biological fluids
WO2020263759A2 (en) 2019-06-22 2020-12-30 Cerus Corporation Biological fluid treatment systems
JP2022539154A (en) 2019-06-28 2022-09-07 シーラス コーポレイション Systems and methods for implementing biological fluid handling devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091385A (en) * 1988-09-30 1992-02-25 Baylor Research Institute Pre-activated therapeutic agents derived from photoactive compounds
IL92996A (en) * 1989-01-10 1996-06-18 Bisaccia Emil Photoactive compounds as medicaments for the treatment of virus infections and method for production of vaccines
DE69330514T2 (en) * 1992-01-27 2002-03-28 Baxter International Inc., Deerfield METHOD FOR INACTIVATING VIRALS, PARASITARIES AND BACTERIAL BLOOD IMPURITIES
AU703108B2 (en) * 1995-06-07 1999-03-18 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants

Also Published As

Publication number Publication date
AU3638595A (en) 1996-04-09
AU691672B2 (en) 1998-05-21
CA2199372A1 (en) 1996-03-28
WO1996008965A1 (en) 1996-03-28
NO971350L (en) 1997-05-22
EP0782388A1 (en) 1997-07-09
EP0782388A4 (en) 2000-03-08

Similar Documents

Publication Publication Date Title
NO971350D0 (en) Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
ZA912842B (en) Method of inactivation of viral and bacterial blood contaminants
NO955291D0 (en) System for viral inactivation of blood
AU7217794A (en) Method of inactivation of viral and bacterial blood contaminants
NO963777D0 (en) Catheter with shaft of varying stiffness
DE69516750D1 (en) Self-propelled wheelchair with adjustable center of gravity and independent suspension
DE69132274D1 (en) METHOD OF BACTERIAL ATTENUATION AND VACCINE
DE69737144D1 (en) ANTIMICROBIAL TREATMENT OF HERPES SIMPLEX VIRUSES AND OTHER INFECTIOUS DISEASES
MA23226A1 (en) OPTICALLY ACTIVE DERIVATIVES OF 2-IMIDAZOLINE-5-ONES AND 2-IMIDAZOLINE-
FI970357A (en) Benzoxazole and pyridine derivatives useful in the treatment of type II diabetes
DE69821796D1 (en) STERILIZATION OF GLUCOCORTICOSTEROIDS
DE69718399D1 (en) Dilatation and centering catheter
BR9406209A (en) Heterocyclic derivatives in the treatment of ischemia and related diseases
FI954047A0 (en) Purification of human interleukin-10
FI965204A (en) Medical use of bromelain
BR9508539A (en) Triazine derivative and medicine
DE69705324D1 (en) N-HYDROXY-URINE DERIVATIVES AND MEDICAL PREPARATIONS CONTAINING THEM
DK118995A (en) Wheel hub with suspension and use of such wheel hub
BR9707348A (en) Process and disinfection of sensitive medical instruments
NO940810D0 (en) Treatment of viral infections
NO955258D0 (en) Medical use of enzymes
NO975683D0 (en) Method of inactivating viral and bacterial blood contaminants
FI956313A (en) Metamorphic treatment of alloys and their products
BR9708510A (en) New furan diarylmethylidene derivatives their preparation procedures and their therapeutic uses
FI971897A (en) Detection of human retroviral infection

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application